How well do in vitro particle size measurements predict drag delivery in vivo?

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Newman, Stephen P ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; CONFERENCE PAPER; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; GAMMA SCINTIGRAPHY; LUNG; METERED DOSE INHALER; PARTICLE SIZE;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG DELIVERY SYSTEMS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS;

EID: 0031804508     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. British Association for Lung Research. 1995. Workshop report. British Association for Lung Research Consensus Statement. Determining equivalence of inhaled medications. Respir. Med. 89:253-261.
2. Davis, S.S., J.G. Hardy, S.P. Newman, and I.R. Wilding. 1992. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 19:971-986.
3. Newman, S.P. 1993. Scintigraphic assessment of therapeutic aerosols. Crit. Rev. Ther. Drug Carrier Syst. 10:65-109.
4. Newman, S.P. 1993. Therapeutic aerosol deposition in man. In F. Morén, M.B. Dolovich, M.T. Newhouse, and S.P. Newman, eds. Aerosols in Medicine: Principles, Diagnosis and Therapy. Elsevier, Amsterdam, 375-399.
5. Brain, J.D., and J.D. Blanchard. 1993. Mechanisms of particle deposition and clearance. In F. Moren, M.B. Dolovich, M.T. Newhouse, and S.P. Newman, eds. Aerosols in Medicine: Principles, Diagnosis and Therapy. Elsevier, Amsterdam, 117-156.
6. Hallworth, G.W. 1993. Particle size analysis of therapeutic aerosols. In F. Morén, M.B. Dolovich, M.T. Newhouse, and S.P. Newman, eds. Aerosols in Medicine: Principles, Diagnosis and Therapy. Elsevier: Amsterdam, 351-374.
7. Hindle, M., P.R. Byron, and N.C. Miller. 1996. Cascade impaction methods for dry powder inhalers using the high flowrate Marple-Miller impactor. Int. J. Pharm. 134:137-146.
8. Ross, D.L., and R.K. Schultz. 1996. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler and metered dose inhaler products. J. Aerosol Med. 9:215-226.
9. Zainudin, B.M.Z., M. Biddiscombe, S.E.J. Tolfree, M. Short, and S.G. Spiro. 1990. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax. 45:469-473.
10. Colthorpe, P., S.J. Farr, I.J. Smith, D. Wyatt, and G. Taylor. 1995. The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits. Pharm. Res. 12:356-359.
11. Camner, P., and K. Philipson. 1978. Human alveolar deposition of 4 μm Teflon particles. Arch. Environ. Health. 36:171-175.
12. Thomas, S.H.L., M.J. O'Docherty, C.J. Page, T.O. Nunan, and N.T. Bateman. 1991. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur. Respir. J. 4:616-622.
13. Gonda, I. 1996. Scintigraphic techniques for measuring in vivo deposition. J. Aerosol Med. 9(Suppl 1):S59-S67.
14. Martonen, T.B., I. Katz, K. Fults, and A.J. Hickey. 1992. Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns. Pharm. Res. 9:1634-1639.
15. Clark, A.R. 1991. In-vitro assessment of spacers and reservoir devices. In Proceedings of the Second Respiratory Drug Delivery Conference, Lexington, KY, 470-482.
16. Clark, A.R. 1995. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulisers. Int. J. Pharm. 115:69-78.
17. Newman, S.P. 1996. Characteristics of radiolabelled versus unlabelled formulations. J. Aerosol Med. 9(Suppl 1):S37-S47.
18. Newman, S.P., A.R. Clark, N. Talaee, and S.W. Clarke. 1989. Pressurised aerosol deposition in the human lung with and without an "open" spacer. Thorax. 44:706-710.
19. Pitcaim, G.R., and S.P. Newman. Tissue attenuation corrections in gamma scintigraphy. J. Aerosol Med. 10:187-198.
20. 1993. Multistage liquid impinger. United States Pharmacopeia. 19:5463.
21. Newman, S.P., K.P. Steed, G. Hooper, A. Källén, and L. Borgström. 1995. Comparisons of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler. Pharm. Res. 12:231-236.
22. Olsson, B., L. Borgström, L. Asking, and E. Bondesson. 1996. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. In R.N. Dalby, P.R. Byron, and S.J. Farr, eds. Respiratory Drug Delivery V. Interpharm Press, Buffalo Grove, IL, 273-281.
23. Swift, D.L. 1992. Apparatus and method for measuring regional distribution of therapeutic aerosols and comparing delivery systems. J. Aerosol Sci. 23(Suppl 1):S495-S498.
24. Niven, R.W., F.D. Lott, A.Y. Ip, K.D. Somaratne, and M. Kearney. 1994. Development and use of an in vitro system to evaluate inhaler devices. Int. J. Pharm. 101:81-87.
25. Van Oort, M., and W. Roberts. 1996. Variable flow-variable stage-variable volume strategy for cascade impaction testing of inhalation aerosols. In R.N. Dalby, P.R. Byron, and S.J. Farr, eds. Respiratory Drug Delivery V. Interpharm Press, Buffalo Grove, IL, 418-420.
26. Brindley, A., K.J. Reavill, B.S. Sumby, and I.J. Smith. 1994. The in-vitro characterization of inhalation devices using the electronic lung. In R.N. Dalby, P.R. Byron, and S.J. Farr, eds. Respiratory Drug Delivery V. Interpharm Press, Buffalo Grove, IL, 143-151 .
27. Clark, A.R. 1996. MDIs: Physics of aerosol formation. J. Aerosol Med. 9(Suppl 1):S19-S26.